Mercaptopurine Tablets 50 mg USP 25 Count
How to Order:
You will receive instructions on how to create an account along with Rx Ordering Details.
(Note: Acceptable licenses must have Prescriptive Authority in the license issuing state.)
Mercaptopurine Tablets by Hikma are a critical component in the management of certain leukemias. These tablets provide a reliable oral chemotherapy option aimed at inhibiting cancer cell proliferation in acute lymphoblastic leukemia (ALL).
Usage: Mercaptopurine is primarily used in the treatment of acute lymphoblastic leukemia. It may also be prescribed as part of maintenance therapy in suitable regimens for other hematologic cancers.
Dosage:
- Standard Dosage: Typically 1.5 to 2.5 mg/kg of body weight per day, administered as a single dose.
- Dosage adjustments may be necessary based on tolerance and response.
- Always follow the specific dosing instructions provided by a healthcare provider.
CDC Guidelines: The CDC highlights the importance of individualized cancer treatment plans and regular monitoring of blood counts during chemotherapy. Proper handling and administration procedures should be followed to ensure patient safety and efficacy.
Details and Features:
- Strength: 50 mg per tablet
- Count: 25 tablets per bottle
- Oral Chemotherapy: Convenient for outpatient management
- Effective Leukemia Management: Targets cell proliferation in hematologic malignancies
Mechanism of Action: Mercaptopurine interferes with nucleotide synthesis by incorporating into DNA and RNA, inhibiting the synthesis and function of purine nucleotides. This disrupts the growth and replication of cancer cells, leading to cell death.
Directions for Use:
- Take tablets orally with or without food.
- Maintain a consistent dosing schedule as prescribed by the healthcare provider.
- Regular blood tests are required to monitor response and adjust dosage.
Warnings:
- Monitor liver function and blood counts regularly due to the risk of toxicity.
- Use with caution in patients with hepatic or renal impairment.
- Avoid use in patients with known hypersensitivity to mercaptopurine.
Side Effects: Possible side effects include:
- Bone marrow suppression
- Liver toxicity
- Nausea
- Vomiting
- Rash In the case of severe adverse reactions, seek immediate medical assistance.
Mercaptopurine Tablets by Hikma provide a trusted and effective option in the fight against leukemia, supporting patient outcomes through targeted therapeutic action.